Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “AstraZeneca”
- A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With TezepelumabActive Not Recruiting
Sponsor: AstraZeneca
Chronic Rhinosinusitis With Nasal Polyps
United States, Bulgaria, Canada, France, Germany +4 more
Sponsor: AstraZeneca
Hepatic Impairment
United States
Sponsor: AstraZeneca
Type 2 Diabetes Mellitus
United States, Australia, Bulgaria, Canada, China +8 more
Sponsor: AstraZeneca
Limited Stage Small-Cell Lung Cancer
China
Sponsor: AstraZeneca
Urinary Bladder Neoplasms · Immune Checkpoint Inhibitors · Methotrexate · Vinblastine
Australia, Brazil, Canada, France, Italy +2 more
Sponsor: AstraZeneca
Pancreatic Cancer
Denmark, Finland, France, Norway, Spain +2 more
- Phase IIa Study Evaluating AZD7798 in Crohn's DiseaseActive Not Recruiting
Sponsor: AstraZeneca
Moderate to Severe Crohn's Disease
United States, Argentina, Australia, Belgium, Brazil +21 more
Sponsor: AstraZeneca
Breast Cancer
China
- PICAROS - Acalabrutinib RWE on 1L CLL in SpainActive Not Recruiting
Sponsor: AstraZeneca
Chronic Lymphocytic Leukemia
Spain
- A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast CancerActive Not Recruiting
Sponsor: AstraZeneca
Triple Negative Breast Neoplasms
United States, Canada, Poland, South Korea, Taiwan +1 more
Sponsor: AstraZeneca
Type 2 Diabetes Mellitus
United States, Argentina, China, Denmark, Greece +8 more
Sponsor: AstraZeneca
Healthy Participants
United States
Sponsor: AstraZeneca
Type 2 Diabetes Mellitus · Type 2 Diabetes With Chronic Kidney Disease
United States, Bulgaria, China, Denmark, Germany +11 more
Sponsor: AstraZeneca
Type 2 Diabetes Mellitus
United States, Argentina, Brazil, China, Czechia +19 more
- A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer (LAURA)Active Not Recruiting
Sponsor: AstraZeneca
Non Small Cell Lung Cancer (Stage III)
United States, Argentina, Brazil, China, Hungary +12 more
- Observational Study to Characterize Patients Experiencing Major Acute Bleeding Events During Anticoagulation Treatment With Oral Factor Xa Inhibitors.Active Not Recruiting
Sponsor: Fadoi Foundation, Italy
Major Bleeding · Major Bleeding Outcomes
Italy
Sponsor: AstraZeneca
Ovarian Cancer
Brazil
Sponsor: AstraZeneca
Lung Cancer
Brazil
Sponsor: AstraZeneca
Carcinoma, Non-Small Cell Lung
United States, Argentina, Australia, Belgium, Brazil +22 more
- A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast CancerActive Not Recruiting
Sponsor: AstraZeneca
Metastatic Breast Cancer
United States, Australia, Belgium, Brazil, Canada +5 more
- Lung Cancer Screening Implementation Project in the Brazilian Public Health Care System (LUSIP)Not Yet Recruiting
Sponsor: AstraZeneca
Lung Cancer
Brazil
Sponsor: University of North Carolina, Chapel Hill
Hidradenitis Suppurativa · Acne Inversa · Hidradenitis
United States
- A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCCActive Not Recruiting
Sponsor: AstraZeneca
Advanced Clear Cell Renal Cell Carcinoma
Australia, South Korea
- A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC)Active Not Recruiting
Sponsor: AstraZeneca
Stage II-IIIB Non-small Cell Lung Carcinoma
United States, Hong Kong, Italy, Malaysia, Philippines +6 more
- Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd TherapyEnrolling By Invitation
Sponsor: UNICANCER
Breast Cancer Metastatic · Breast Cancer Stage IV
France